Catalyst Wire Dossier Catalyst Wire Dossier

MGCD290

MGCD290 · MethylGene Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MGCD290, covering 2013-04-04 to 2013-04-04. Get the full timeline:

Most recent: Clinical Trial Update: MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis [Phase 2]

See pricing